1. Australasian Sexual Health Alliance (ASHA). Australian STI management guidelines for use in primary care [internet]. Taking a sexual history and contact tracing. Updated December 2018. Available at: (last accessed 3 September 2019).

  1. Grant RM, Sevelius JM, Guanira JV, Aguilar JV, Chariyalertsak S, Deutsch MB. Transgender women in clinical trials of pre-exposure prophylaxis. J Acquir Immune Defic Syndr 2016;72 Suppl 3:S226-9.

  1. Grant RM, Lama JR, Anderson PL, et al; iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363:2587-99.

  1. Mehrotra ML, Westreich D, McMahan VM, et al. Baseline characteristics explain differences in effectiveness of randomization to daily oral TDF/FTC PrEP between transgender women and cisgender men who have sex with men in the iPrEx Trial. J Acquir Immune Defic Syndr 2019; 81:e94-8

  1. Centers for Disease Control and Prevention (CDC). Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services. MMWR Recomm Rep 2012;61(RR-5):1–40.

  1. International Network of People who Use Drugs (INPUD). Position paper: pre-exposure prophylaxis (PrEP) for people who inject drugs. April 2015. Available at: (last accessed 3 September 2019).

  1. Wodak A, Maher L. The effectiveness of harm reduction in preventing HIV among injecting drug users. NSW Public Health Bulletin 2010;21(3–4):69-73.

  1. Kwon JA, Iversen J, Law M, Dolan K, Wand H, Maher L. Estimating the number of people who inject drugs and syringe coverage in Australia, 2005-2016. Drug Alcohol Depend 2019;197:108-14.

  1. Bazzi AR, Drainoni ML, Biancarelli DL, et al. Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions. BMC Public Health 2019;19:31.

  1. Biello KB, Bazzi AR, Mimiaga MJ, et al. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Harm Reduct J 2018;15:55.